Obesity drugmaker BioAge targets $158 million in IPO 0 19.09.2024 00:57 Fortune.com The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday. Read More Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
